Copyright Reports & Markets. All rights reserved.

Global Heparin API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Heparin API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Heparin Sodium
    • 1.3.3 Heparin Calcium
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Heparin API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 UFH
    • 1.4.3 LMWH
  • 1.5 Global Heparin API Market Size & Forecast
    • 1.5.1 Global Heparin API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Heparin API Sales Quantity (2021-2032)
    • 1.5.3 Global Heparin API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Yantai Dongcheng Pharmaceutical
    • 2.1.1 Yantai Dongcheng Pharmaceutical Details
    • 2.1.2 Yantai Dongcheng Pharmaceutical Major Business
    • 2.1.3 Yantai Dongcheng Pharmaceutical Heparin API Product and Services
    • 2.1.4 Yantai Dongcheng Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
  • 2.2 Shenzhen Hepalink Pharmaceutical
    • 2.2.1 Shenzhen Hepalink Pharmaceutical Details
    • 2.2.2 Shenzhen Hepalink Pharmaceutical Major Business
    • 2.2.3 Shenzhen Hepalink Pharmaceutical Heparin API Product and Services
    • 2.2.4 Shenzhen Hepalink Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Heparin API Product and Services
    • 2.3.4 Pfizer Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Nanjing King-friend Biochemical Pharmaceutical
    • 2.4.1 Nanjing King-friend Biochemical Pharmaceutical Details
    • 2.4.2 Nanjing King-friend Biochemical Pharmaceutical Major Business
    • 2.4.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Product and Services
    • 2.4.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
  • 2.5 Bioibérica
    • 2.5.1 Bioibérica Details
    • 2.5.2 Bioibérica Major Business
    • 2.5.3 Bioibérica Heparin API Product and Services
    • 2.5.4 Bioibérica Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bioibérica Recent Developments/Updates
  • 2.6 Changzhou Qianhong Biopharma
    • 2.6.1 Changzhou Qianhong Biopharma Details
    • 2.6.2 Changzhou Qianhong Biopharma Major Business
    • 2.6.3 Changzhou Qianhong Biopharma Heparin API Product and Services
    • 2.6.4 Changzhou Qianhong Biopharma Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Changzhou Qianhong Biopharma Recent Developments/Updates
  • 2.7 Hebei Changshan Biochemical Pharmaceutical
    • 2.7.1 Hebei Changshan Biochemical Pharmaceutical Details
    • 2.7.2 Hebei Changshan Biochemical Pharmaceutical Major Business
    • 2.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Product and Services
    • 2.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
  • 2.8 Qingdao Jiulong Biopharmaceutical
    • 2.8.1 Qingdao Jiulong Biopharmaceutical Details
    • 2.8.2 Qingdao Jiulong Biopharmaceutical Major Business
    • 2.8.3 Qingdao Jiulong Biopharmaceutical Heparin API Product and Services
    • 2.8.4 Qingdao Jiulong Biopharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
  • 2.9 Opocrin
    • 2.9.1 Opocrin Details
    • 2.9.2 Opocrin Major Business
    • 2.9.3 Opocrin Heparin API Product and Services
    • 2.9.4 Opocrin Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Opocrin Recent Developments/Updates
  • 2.10 Dongying Tiandong Pharmaceutical
    • 2.10.1 Dongying Tiandong Pharmaceutical Details
    • 2.10.2 Dongying Tiandong Pharmaceutical Major Business
    • 2.10.3 Dongying Tiandong Pharmaceutical Heparin API Product and Services
    • 2.10.4 Dongying Tiandong Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
  • 2.11 Aspen Oss
    • 2.11.1 Aspen Oss Details
    • 2.11.2 Aspen Oss Major Business
    • 2.11.3 Aspen Oss Heparin API Product and Services
    • 2.11.4 Aspen Oss Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Aspen Oss Recent Developments/Updates
  • 2.12 Yino Pharma
    • 2.12.1 Yino Pharma Details
    • 2.12.2 Yino Pharma Major Business
    • 2.12.3 Yino Pharma Heparin API Product and Services
    • 2.12.4 Yino Pharma Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Yino Pharma Recent Developments/Updates
  • 2.13 Hubei Enoray Biopharmaceutical
    • 2.13.1 Hubei Enoray Biopharmaceutical Details
    • 2.13.2 Hubei Enoray Biopharmaceutical Major Business
    • 2.13.3 Hubei Enoray Biopharmaceutical Heparin API Product and Services
    • 2.13.4 Hubei Enoray Biopharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
  • 2.14 Cisen Pharmaceutical
    • 2.14.1 Cisen Pharmaceutical Details
    • 2.14.2 Cisen Pharmaceutical Major Business
    • 2.14.3 Cisen Pharmaceutical Heparin API Product and Services
    • 2.14.4 Cisen Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Cisen Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Heparin API by Manufacturer

  • 3.1 Global Heparin API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Heparin API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Heparin API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Heparin API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Heparin API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Heparin API Manufacturer Market Share in 2025
  • 3.5 Heparin API Market: Overall Company Footprint Analysis
    • 3.5.1 Heparin API Market: Region Footprint
    • 3.5.2 Heparin API Market: Company Product Type Footprint
    • 3.5.3 Heparin API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Heparin API Market Size by Region
    • 4.1.1 Global Heparin API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Heparin API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Heparin API Average Price by Region (2021-2032)
  • 4.2 North America Heparin API Consumption Value (2021-2032)
  • 4.3 Europe Heparin API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Heparin API Consumption Value (2021-2032)
  • 4.5 South America Heparin API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Heparin API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Heparin API Sales Quantity by Type (2021-2032)
  • 5.2 Global Heparin API Consumption Value by Type (2021-2032)
  • 5.3 Global Heparin API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Heparin API Sales Quantity by Application (2021-2032)
  • 6.2 Global Heparin API Consumption Value by Application (2021-2032)
  • 6.3 Global Heparin API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Heparin API Sales Quantity by Type (2021-2032)
  • 7.2 North America Heparin API Sales Quantity by Application (2021-2032)
  • 7.3 North America Heparin API Market Size by Country
    • 7.3.1 North America Heparin API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Heparin API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Heparin API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Heparin API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Heparin API Market Size by Country
    • 8.3.1 Europe Heparin API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Heparin API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Heparin API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Heparin API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Heparin API Market Size by Region
    • 9.3.1 Asia-Pacific Heparin API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Heparin API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Heparin API Sales Quantity by Type (2021-2032)
  • 10.2 South America Heparin API Sales Quantity by Application (2021-2032)
  • 10.3 South America Heparin API Market Size by Country
    • 10.3.1 South America Heparin API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Heparin API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Heparin API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Heparin API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Heparin API Market Size by Country
    • 11.3.1 Middle East & Africa Heparin API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Heparin API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Heparin API Market Drivers
  • 12.2 Heparin API Market Restraints
  • 12.3 Heparin API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Heparin API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Heparin API
  • 13.3 Heparin API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Heparin API Typical Distributors
  • 14.3 Heparin API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Heparin API market size was valued at US$ 1511 million in 2025 and is forecast to a readjusted size of US$ 2508 million by 2032 with a CAGR of 7.6% during review period.
    Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin API is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin API product is existed in a form of Heparin Sodium API or Heparin Calcium API.
    Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
    The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.
    The expanding healthcare sector, coupled with a rising prevalence of cardiovascular diseases and thrombotic disorders, continues to drive demand for Heparin Active Pharmaceutical Ingredient (API). The growing global aging population and increasing awareness about these medical conditions have further intensified the need for effective anticoagulant therapies. Additionally, advancements in medical research and development, alongside the escalating number of surgical procedures, contribute to the sustained growth of the Heparin API market. While, one of the significant challenges in the Heparin API market is the vulnerability of its supply chain. Dependence on porcine mucosa as the primary source, coupled with supply disruptions due to disease outbreaks and geopolitical factors, poses a risk to consistent availability. Moreover, ensuring the quality and safety of Heparin APIs remains a concern, with regulatory scrutiny focused on preventing adulteration and contamination. Balancing these challenges while navigating competition from alternative anticoagulants and addressing complex production processes poses ongoing difficulties for industry stakeholders.
    The classification of Heparin includes Heparin Sodium and Heparin Calcium. In 2024, Heparin Sodium accounted for a revenue share of 96.63% in the global Heparin market. In addition, this product segment is poised to reach US$ 2,228.35 million by 2031 from US$ 1,184.01 million in 2024.
    Heparin is widely used for UFH and LMWH. In Heparin market, the LMWH holds an important share in terms of application, and it is expected to reach a value of US$ 1,977.66 million by 2031, at a CAGR of 7.94% during 2025 and 2031.
    Europe is the largest consumption place, with a revenue market share nearly 36.86% in 2024. China is the worlds’ largest pig production, which supplied by sufficient raw materials.
    North American market for Heparin API is estimated to increase from $ 431.49 million in 2025 to reach $ 671.33 million by 2031, at a CAGR of 7.65% during the forecast period of 2025 through 2031.
    Asia-Pacific market for Heparin API is estimated to increase from $ 478.50 million in 2025 to reach $ 799.46 million by 2031, at a CAGR of 8.93% during the forecast period of 2025 through 2031.
    Europe market for Heparin API is estimated to increase from $ 537.57 million in 2025 to reach $ 801.22 million by 2031, at a CAGR of 6.88% during the forecast period of 2025 through 2031.
    The global key companies of Heparin Active Pharmaceutical Ingredients include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and Dongying Tiandong Pharmaceutical, etc. In 2024, the global five largest players hold a share approximately 55.0% in terms of revenue.
    This report is a detailed and comprehensive analysis for global Heparin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Heparin API market size and forecasts, in consumption value ($ Million), sales quantity (Billion Units), and average selling prices (USD/Billion Units), 2021-2032
    Global Heparin API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Billion Units), and average selling prices (USD/Billion Units), 2021-2032
    Global Heparin API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Billion Units), and average selling prices (USD/Billion Units), 2021-2032
    Global Heparin API market shares of main players, shipments in revenue ($ Million), sales quantity (Billion Units), and ASP (USD/Billion Units), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Heparin API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Heparin API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Pfizer, Nanjing King-friend Biochemical Pharmaceutical, Bioibérica, Changzhou Qianhong Biopharma, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Heparin API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Heparin Sodium
    Heparin Calcium
    Market segment by Application
    UFH
    LMWH
    Major players covered
    Yantai Dongcheng Pharmaceutical
    Shenzhen Hepalink Pharmaceutical
    Pfizer
    Nanjing King-friend Biochemical Pharmaceutical
    Bioibérica
    Changzhou Qianhong Biopharma
    Hebei Changshan Biochemical Pharmaceutical
    Qingdao Jiulong Biopharmaceutical
    Opocrin
    Dongying Tiandong Pharmaceutical
    Aspen Oss
    Yino Pharma
    Hubei Enoray Biopharmaceutical
    Cisen Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Heparin API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Heparin API, with price, sales quantity, revenue, and global market share of Heparin API from 2021 to 2026.
    Chapter 3, the Heparin API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Heparin API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Heparin API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin API.
    Chapter 14 and 15, to describe Heparin API sales channel, distributors, customers, research findings and conclusion.

    Buy now